View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsDSM-Firmenich 配当と自社株買い配当金 基準チェック /06DSM-Firmenich配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長6.4%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向96%最近の配当と自社株買いの更新お知らせ • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).すべての更新を表示Recent updatesRecent Insider Transactions • Apr 05Key Executive recently sold €438k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 4k shares on-market at roughly €106 per share. This transaction amounted to 3.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Dimitri's only on-market trade for the last 12 months.Reported Earnings • Feb 20Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)Full year 2022 results: EPS: €2.63 (down from €6.25 in FY 2021). Revenue: €8.39b (down 8.8% from FY 2021). Net income: €454.0m (down 58% from FY 2021). Profit margin: 5.4% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.Recent Insider Transactions • Nov 16Key Executive recently bought €587k worth of stockOn the 7th of November, Thomas Leysen bought around 5k shares on-market at roughly €117 per share. This transaction amounted to 99% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Thomas' only on-market trade for the last 12 months.お知らせ • Nov 01Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023Koninklijke DSM N.V. announced that they will report fiscal year 2022 results on Feb 16, 2023Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)First half 2022 results: EPS: €1.68 (down from €2.41 in 1H 2021). Revenue: €4.12b (down 8.3% from 1H 2021). Net income: €290.0m (down 30% from 1H 2021). Profit margin: 7.0% (down from 9.3% in 1H 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 4.6%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 12% per year.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €159, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 62% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €141 per share.Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).Executive Departure • May 12Independent Deputy Chairwoman of Supervisory Board has left the companyOn the 6th of May, Pauline Francoise van der Meer Mohr's tenure as Independent Deputy Chairwoman of Supervisory Board ended after 10.0 years in the role. As of December 2020, Pauline Francoise personally held 1.53k shares (€219k worth at the time). A total of 4 executives have left over the last 12 months.Executive Departure • May 12Independent Chairman of Supervisory Board Robert Routs has left the companyOn the 6th of May, Robert Routs' tenure as Independent Chairman of Supervisory Board ended after 10.0 years in the role. We don't have any record of a personal shareholding under Robert's name. A total of 4 executives have left over the last 12 months.Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).Recent Insider Transactions • Apr 04Key Executive recently sold €750k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 16k shares on-market at roughly €46.49 per share. This was the largest sale by an insider in the last 3 months. Dimitri has been a seller over the last 12 months, reducing personal holdings by €1.0m.Reported Earnings • Feb 20Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €8.11b (down 10.0% from FY 2019). Net income: €452.0m (down 40% from FY 2019). Profit margin: 5.6% (down from 8.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Feb 20Revenue misses expectationsRevenue missed analyst estimates by 4.2%. Over the next year, revenue is forecast to grow 7.4%, compared to a 5.2% growth forecast for the Chemicals industry in Germany.Is New 90 Day High Low • Feb 04New 90-day high: €149The company is up 1.0% from its price of €147 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.Is New 90 Day High Low • Sep 30New 90-day high: €141The company is up 13% from its price of €125 on 02 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €70.41 per share.決済の安定と成長配当データの取得安定した配当: DSM2の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: DSM2の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場DSM-Firmenich 配当利回り対市場DSM2 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (DSM2)n/a市場下位25% ()0%市場トップ25% ()0%業界平均 (Chemicals)0%アナリスト予想 (DSM2) (最長3年)n/a注目すべき配当: DSM2は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: DSM2は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: DSM2 German市場において目立った配当金を支払っていません。株主配当金キャッシュフローカバレッジ: DSM2の 現金配当性向 を計算して、配当金の支払いがキャッシュフローでカバーされているかどうかを判断するにはデータが不十分です。高配当企業の発掘7D1Y7D1Y7D1YDE 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析終値収益年間収益データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋DSM-Firmenich AG 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。44 アナリスト機関Jennifer BarkerBarclaysAlexander SloaneBarclaysSebastian BrayBerenberg41 その他のアナリストを表示
お知らせ • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.
Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).
Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).
Recent Insider Transactions • Apr 05Key Executive recently sold €438k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 4k shares on-market at roughly €106 per share. This transaction amounted to 3.4% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Dimitri's only on-market trade for the last 12 months.
Reported Earnings • Feb 20Full year 2022 earnings released: EPS: €2.63 (vs €6.25 in FY 2021)Full year 2022 results: EPS: €2.63 (down from €6.25 in FY 2021). Revenue: €8.39b (down 8.8% from FY 2021). Net income: €454.0m (down 58% from FY 2021). Profit margin: 5.4% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 1.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 18DSM Firmenich Announces Intention Pay Final Gross DividendDSM Firmenich announced intention to pay a gross dividend of EUR 423 million, which will be almost EUR 1.6 per share as a sort of final dividend.
Recent Insider Transactions • Nov 16Key Executive recently bought €587k worth of stockOn the 7th of November, Thomas Leysen bought around 5k shares on-market at roughly €117 per share. This transaction amounted to 99% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Thomas' only on-market trade for the last 12 months.
お知らせ • Nov 01Koninklijke DSM N.V. to Report Fiscal Year 2022 Results on Feb 16, 2023Koninklijke DSM N.V. announced that they will report fiscal year 2022 results on Feb 16, 2023
Reported Earnings • Aug 03First half 2022 earnings released: EPS: €1.68 (vs €2.41 in 1H 2021)First half 2022 results: EPS: €1.68 (down from €2.41 in 1H 2021). Revenue: €4.12b (down 8.3% from 1H 2021). Net income: €290.0m (down 30% from 1H 2021). Profit margin: 7.0% (down from 9.3% in 1H 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 4.6%, compared to a 6.1% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 12% per year.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to €159, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 11x in the Chemicals industry in Germany. Total returns to shareholders of 62% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €141 per share.
Upcoming Dividend • May 05Upcoming dividend of €1.70 per shareEligible shareholders must have bought the stock before 12 May 2022. Payment date: 01 June 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (4.1%). Lower than average of industry peers (5.0%).
Executive Departure • May 12Independent Deputy Chairwoman of Supervisory Board has left the companyOn the 6th of May, Pauline Francoise van der Meer Mohr's tenure as Independent Deputy Chairwoman of Supervisory Board ended after 10.0 years in the role. As of December 2020, Pauline Francoise personally held 1.53k shares (€219k worth at the time). A total of 4 executives have left over the last 12 months.
Executive Departure • May 12Independent Chairman of Supervisory Board Robert Routs has left the companyOn the 6th of May, Robert Routs' tenure as Independent Chairman of Supervisory Board ended after 10.0 years in the role. We don't have any record of a personal shareholding under Robert's name. A total of 4 executives have left over the last 12 months.
Upcoming Dividend • May 03Upcoming dividend of €1.60 per shareEligible shareholders must have bought the stock before 10 May 2021. Payment date: 03 June 2021. Trailing yield: 1.6%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.6%).
Recent Insider Transactions • Apr 04Key Executive recently sold €750k worth of stockOn the 31st of March, Dimitri de Vreeze sold around 16k shares on-market at roughly €46.49 per share. This was the largest sale by an insider in the last 3 months. Dimitri has been a seller over the last 12 months, reducing personal holdings by €1.0m.
Reported Earnings • Feb 20Full year 2020 earnings released: EPS €2.64 (vs €4.27 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €8.11b (down 10.0% from FY 2019). Net income: €452.0m (down 40% from FY 2019). Profit margin: 5.6% (down from 8.3% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 46% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Feb 20Revenue misses expectationsRevenue missed analyst estimates by 4.2%. Over the next year, revenue is forecast to grow 7.4%, compared to a 5.2% growth forecast for the Chemicals industry in Germany.
Is New 90 Day High Low • Feb 04New 90-day high: €149The company is up 1.0% from its price of €147 on 05 November 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 25% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €120 per share.
Is New 90 Day High Low • Sep 30New 90-day high: €141The company is up 13% from its price of €125 on 02 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €70.41 per share.